Workflow
动量投资
icon
Search documents
Garmin (GRMN) is a Great Momentum Stock: Should You Buy?
ZACKS· 2025-07-31 17:00
Company Overview - Garmin (GRMN) currently holds a Momentum Style Score of A, indicating strong potential for momentum investing [3] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for outperformance in the market [4] Price Performance - Over the past week, Garmin shares have increased by 3.4%, outperforming the Zacks Electronics - Miscellaneous Products industry, which rose by 0.71% [6] - In a longer time frame, Garmin's shares have increased by 3.8% over the past month, compared to the industry's 0.42% [6] - Over the past quarter, Garmin shares have surged by 17.65%, and over the last year, they have gained 29.34%, while the S&P 500 has only moved 14.59% and 18.48%, respectively [7] Trading Volume - Garmin's average 20-day trading volume is 801,175 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, one earnings estimate for Garmin has been revised upward, while none have been revised downward, leading to an increase in the consensus estimate from $7.94 to $7.97 [10] - For the next fiscal year, one estimate has also moved upwards with no downward revisions during the same period [10] Conclusion - Given the strong price performance, positive earnings outlook, and high Momentum Style Score, Garmin is recommended as a solid momentum pick for investors [12]
BioNTech SE Sponsored ADR (BNTX) Is Up 4.81% in One Week: What You Should Know
ZACKS· 2025-07-30 17:00
Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Group 1: Company Overview - BioNTech SE Sponsored ADR (BNTX) currently holds a Momentum Style Score of A, indicating strong momentum characteristics [3] - The company has a Zacks Rank of 1 (Strong Buy), suggesting a favorable outlook based on historical performance metrics [4] Group 2: Performance Metrics - Over the past week, BNTX shares increased by 4.81%, outperforming the Zacks Medical - Biomedical and Genetics industry, which rose by 1.8% [6] - In the last quarter, BNTX shares rose by 17.67%, and over the past year, they increased by 28.52%, while the S&P 500 saw gains of 14.96% and 18.01%, respectively [7] Group 3: Trading Volume - BNTX's average 20-day trading volume is 603,221 shares, which serves as a bullish indicator when combined with rising stock prices [8] Group 4: Earnings Outlook - In the past two months, five earnings estimates for BNTX have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from -$6.68 to -$3.91 [10] - For the next fiscal year, four estimates have also moved higher, indicating positive sentiment regarding future earnings [10] Group 5: Conclusion - Given the strong performance metrics and positive earnings outlook, BNTX is positioned as a promising investment opportunity with a Momentum Score of A [12]
What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now?
ZACKS· 2025-07-30 17:00
Company Overview - Connect Biopharma Holdings Limited Sponsored ADR (CNTB) currently holds a Momentum Style Score of A, indicating strong potential for momentum investing [3] - The company has a Zacks Rank of 2 (Buy), which is supported by a historical track record of outperforming the market [4] Price Performance - CNTB shares have increased by 29.07% over the past week, significantly outperforming the Zacks Medical - Biomedical and Genetics industry, which rose by 1.8% during the same period [6] - Over the past month, CNTB's price change is 65.09%, compared to the industry's 5.63% [6] - In the last quarter, CNTB shares have surged by 120.96%, and over the past year, they have gained 47.06%, while the S&P 500 has only moved 14.96% and 18.01%, respectively [7] Trading Volume - The average 20-day trading volume for CNTB is 262,215 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, one earnings estimate for CNTB has moved higher, while none have moved lower, resulting in an increase in the consensus estimate from -$1.12 to -$0.90 [10] - For the next fiscal year, one estimate has also moved upwards with no downward revisions during the same period [10] Conclusion - Given the strong price performance, positive earnings outlook, and high Momentum Style Score, CNTB is positioned as a promising investment opportunity [12]
Despite Fast-paced Momentum, Array Technologies (ARRY) Is Still a Bargain Stock
ZACKS· 2025-07-28 13:50
Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investors often face challenges in determining the right entry point for fast-moving stocks, which can lead to limited upside or downside risks [2] - A safer approach involves investing in bargain stocks that exhibit recent price momentum, utilizing tools like the Zacks Momentum Style Score to identify such opportunities [3] Group 2: Array Technologies, Inc. (ARRY) Analysis - Array Technologies, Inc. (ARRY) has shown a four-week price change of 7.3%, indicating growing investor interest [4] - Over the past 12 weeks, ARRY's stock has gained 37.7%, with a beta of 1.74, suggesting it moves 74% more than the market [5] - ARRY has a Momentum Score of B, indicating a favorable time to invest based on momentum [6] Group 3: Earnings Estimates and Valuation - ARRY has received a Zacks Rank 2 (Buy) due to upward trends in earnings estimate revisions, which attract more investor interest [7] - The stock is currently trading at a Price-to-Sales ratio of 0.99, suggesting it is undervalued at 99 cents for each dollar of sales [7] Group 4: Additional Investment Opportunities - Besides ARRY, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [8] - Investors can explore over 45 Zacks Premium Screens tailored to different investing styles to identify potential winning stocks [9]
DoorDash, Inc. (DASH) Is Up 0.69% in One Week: What You Should Know
ZACKS· 2025-07-17 17:01
Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, with the aim of buying high and selling higher, capitalizing on established price movements [1] Company Overview: DoorDash, Inc. (DASH) - DoorDash currently holds a Momentum Style Score of B, indicating a positive outlook based on price changes and earnings estimate revisions [2] - The company has a Zacks Rank of 1 (Strong Buy), suggesting strong potential for outperformance in the market [3] Performance Metrics - Over the past week, DASH shares increased by 0.69%, while the Zacks Internet - Services industry remained flat [5] - In the last month, DASH's price rose by 6.31%, outperforming the industry's 3.13% [5] - Over the past quarter, DASH shares have surged by 29.42%, and over the last year, they have increased by 127.32%, compared to the S&P 500's gains of 19.12% and 11.85% respectively [6] Trading Volume - The average 20-day trading volume for DASH is 3,846,597 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the last two months, four earnings estimates for DASH have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $2.07 to $2.16 [9] - For the next fiscal year, four estimates have also moved upwards without any downward revisions [9] Conclusion - Given the strong performance metrics and positive earnings outlook, DASH is positioned as a 1 (Strong Buy) stock with a Momentum Score of B, making it a compelling investment option [11]
Sportradar Group AG (SRAD) Is Up 1.20% in One Week: What You Should Know
ZACKS· 2025-07-17 17:01
Group 1 - Momentum investing involves following a stock's recent trend, with the aim of buying high and selling higher, capitalizing on established price movements [1][3] - Sportradar Group AG (SRAD) currently holds a Momentum Style Score of A, indicating strong potential for momentum investing [3][12] - The Zacks Rank for SRAD is 2 (Buy), suggesting it is positioned for outperformance in the market [4][12] Group 2 - SRAD shares have increased by 1.2% over the past week, while the Zacks Leisure and Recreation Products industry has decreased by 0.3% during the same period [6] - Over the last quarter, SRAD shares have risen by 29.57%, and by 161.57% over the past year, significantly outperforming the S&P 500's gains of 19.12% and 11.85% respectively [7] - The average 20-day trading volume for SRAD is 2,008,441 shares, indicating a bullish trend with above-average volume [8] Group 3 - In the past two months, three earnings estimates for SRAD have been revised upwards, increasing the consensus estimate from $0.31 to $0.33 [10] - For the next fiscal year, three estimates have moved higher while one has been revised downwards, reflecting a positive earnings outlook [10]
Gates Industrial (GTES) is a Great Momentum Stock: Should You Buy?
ZACKS· 2025-07-17 17:01
Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Gates Industrial (GTES) - Gates Industrial currently holds a Momentum Style Score of B, indicating a positive momentum outlook [2] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [3] Performance Metrics - GTES shares have increased by 1.79% over the past week, while the Zacks Manufacturing - General Industrial industry has seen a slight decline of 0.01% [5] - Over the past month, GTES has shown a price change of 11.34%, outperforming the industry's 5.09% [5] - In the last quarter, GTES shares have risen by 40.62%, and over the past year, they have gained 39.82%, significantly outperforming the S&P 500's increases of 19.12% and 11.85% respectively [6] Trading Volume - The average 20-day trading volume for GTES is 1,566,129 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, one earnings estimate for GTES has increased, while none have decreased, raising the consensus estimate from $1.42 to $1.43 [9] - For the next fiscal year, one estimate has also moved upwards with no downward revisions noted [9] Conclusion - Given the positive performance metrics and earnings outlook, GTES is positioned as a 2 (Buy) stock with a Momentum Score of B, making it a strong candidate for near-term investment [11]
Roku (ROKU) is a Great Momentum Stock: Should You Buy?
ZACKS· 2025-07-16 17:01
Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Summary: Roku (ROKU) - Roku currently holds a Momentum Style Score of B, indicating a favorable momentum characteristic [2] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [3] - Over the past week, Roku shares increased by 0.82%, while the Zacks Broadcast Radio and Television industry declined by 0.13% [5] - In the last quarter, Roku shares rose by 50.73%, and over the past year, they increased by 37.93%, significantly outperforming the S&P 500, which rose by 16.04% and 12.11% respectively [6] - Roku's average 20-day trading volume is 2,616,092 shares, indicating a bullish sign as the stock is rising with above-average volume [7] Earnings Outlook - In the past two months, one earnings estimate for Roku has increased, while none have decreased, leading to a consensus estimate improvement from -$0.19 to -$0.18 [9] - For the next fiscal year, one estimate has also moved upwards with no downward revisions, indicating positive sentiment [9] Conclusion - Considering the positive momentum indicators and earnings outlook, Roku is positioned as a 2 (Buy) stock with a Momentum Score of B, making it a potential candidate for near-term investment [10][11]
Caterpillar (CAT) Is Up 2.03% in One Week: What You Should Know
ZACKS· 2025-07-16 17:01
Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Caterpillar (CAT) - Caterpillar currently holds a Momentum Style Score of B and a Zacks Rank of 2 (Buy), indicating strong potential for outperformance [2][3] - The stock has shown a price increase of 2.03% over the past week, outperforming the Zacks Manufacturing - Construction and Mining industry, which rose by 0.66% [5] - Over the last month, CAT's shares increased by 13.13%, significantly higher than the industry's 4.7% performance [5] - In the past quarter, CAT shares rose by 38.97%, while the S&P 500 only increased by 16.04% [6] - Year-to-date, CAT's shares are up 12.22%, compared to the S&P 500's 12.11% [6] Trading Volume - The average 20-day trading volume for CAT is 2,584,124 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the last two months, 2 earnings estimates for CAT have been revised upwards, while 1 estimate was revised downwards, leading to an increase in the consensus estimate from $18.73 to $18.80 [9] - For the next fiscal year, 4 estimates have moved upwards with no downward revisions, indicating positive sentiment [9] Conclusion - Given the positive momentum indicators and earnings outlook, CAT is positioned as a strong buy candidate for investors seeking short-term gains [11]
LENZ Therapeutics, Inc. (LENZ) is a Great Momentum Stock: Should You Buy?
ZACKS· 2025-07-16 17:01
Company Overview - LENZ Therapeutics, Inc. currently holds a Momentum Style Score of A, indicating strong momentum characteristics [3] - The company has a Zacks Rank of 2 (Buy), suggesting a favorable outlook for investors [4] Performance Metrics - Over the past week, LENZ shares have increased by 6.64%, outperforming the Zacks Medical - Biomedical and Genetics industry, which rose by 2.16% [6] - In a longer time frame, LENZ's monthly price change is 13.09%, compared to the industry's 3.31% [6] - Over the past quarter, LENZ shares have surged by 26.99%, and over the last year, they have gained 49.13%, while the S&P 500 has only increased by 16.04% and 12.11%, respectively [7] Trading Volume - The average 20-day trading volume for LENZ is 330,002 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, one earnings estimate for LENZ has been revised upward, while none have been revised downward, leading to an increase in the consensus estimate from -$2.85 to -$2.81 [10] - For the next fiscal year, one estimate has also moved upwards with no downward revisions during the same period [10] Conclusion - Given the strong performance metrics and positive earnings outlook, LENZ Therapeutics, Inc. is positioned as a promising investment opportunity with a Momentum Score of A [12]